SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2819Your post made me wonder whatever happened to chemocentryx, the chemokine-focusekeokalani'nui-3/6/2007
2818Just found out that Compugen now has a CCR2 program for chronic inflammatory distuck-3/5/2007
2817Proteasomal inhibition in intracerebral hemorrhage: Neuroprotective and anti-infIcebrg-3/5/2007
2816A Phase 1 Study of the Proteasome Inhibitor Bortezomib in Pediatric Patients witIcebrg-3/5/2007
2815MILLENNIUM PHARMACEUTICALS (MLNM): VELCADE FORMULTIPLE MYELOMA [Supposed to be Icebrg-3/2/2007
2814The following is a list of Rule 144a privately issued convertible securities thaIan@SI-2/20/2007
2813Bortezomib enhances dendritic cell (DC) mediated induction of immunity to human Icebrg-2/16/2007
2812Thank you for your post. I am really more interested in the drug than in the druidos-2/9/2007
2811Totally cool, great news. That's a great hope, that patients can rotate thrscaram(o)uche-2/8/2007
2810Hi Rick; I'm doing very well. It's 10 years since my myeloma diagnosis.Mike K-2/8/2007
2809Thanks, very much, for your thoughts, Mike. Hope you're doing well. Rickscaram(o)uche-2/8/2007
2808Velcade is an important drug for the treatment of myeloma. While it is true thatMike K-2/8/2007
2807Despite tough competition from CELG, Velcade survives very nicely. Am I wrong? idos-2/8/2007
2806It is surprising, that still research is presented with the molecule named PS-34Icebrg-1/26/2007
2805Proteasome inhibitors sensitize ovarian cancer cells to TRAIL induced apoptosis.Icebrg-1/26/2007
2804[HDAC inhibitors (PXD101) and Velcade vs head and neck cancer] >>Mol Canctuck-1/24/2007
2803Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cellIcebrg-1/24/2007
2802Trigen Obtains Exclusive License to GPVI Technology Last Update: 2:11 AM ET Jan Icebrg-1/23/2007
2801[Bortezomib acts differently in combination with p53 gene transfer or cytotoxic tuck-1/22/2007
2800[Bortezomib inhibits cell-cell adhesion and cell migration and enhances epidermatuck-1/22/2007
2799>>Ortho Biotech seeks FDA approval for Doxil in combination with Velcade ttuck-1/22/2007
2798Phase I Trial of First-Line Bortezomib/Thalidomide plus Chemotherapy for InductiIcebrg-1/20/2007
2797Proteolix Elects Dr. Michael Kauffman Chairman of the Board January 18, 2007 - 6Icebrg-1/19/2007
2796I really have no idea. I think, one sees quite often that a drug is claimed to hIcebrg-1/17/2007
2795Is there any possibility that even half the efficacy may be seen in vivo??? <Ian@SI-1/17/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News